QT Imaging Holdings, Inc. is a medical device company engaged in the research, development, and commercialization of body imaging systems using low-frequency sound waves. The Company's products include QTI Breast Acoustic CT Scanner and QTviewer Software. QTI’s Breast Acoustic CT scanner with QTViewer viewer software is the only three-dimensional (3D) imaging device to receive United States Food and Drug Administration (FDA) clearance for use as a transmission and reflection ultrasonic imaging system of a patients breast. QTviewer is its proprietary image viewing and analysis platform, purpose-built to interpret the rich, quantitative datasets generated by the QTI Breast Acoustic CT™ scanner. The QTviewer allows users to rotate, zoom, and cross-navigate entire breast volumes. Whether isolating lesions or exploring architectural distortion, radiologists can interact with the data dynamically to gain an understanding of tissue structure and lesion morphology.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 46796.30% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 18.93M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 18.93M.
Undervalued
The company’s latest PE is -3.87, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.38M shares, decreasing 14.90% quarter-over-quarter.